title: Homocysteine and alpha-1 antitrypsin concentration in patients with subclinical hypercortisolemia.
abstract: OBJECTIVE
  Glucocorticoids have particularly strong impact on the thromboembolic complications. A factor which increases the risk of thrombosis is hyperhomocysteinemia, observed in patients with hypercortisolemia. Proinflammatory factors also affect the haemostatic balance. There has been an extensive research which estimates hemostatic system in patients with Cushing's syndrome. Undoubtedly, much fewer publications are available on thromboembolic complications in patients with Subclinical Cushing's Syndrome (SCS). The purpose of this study was to estimate of homocysteine (HCY) and alpha-1 antitrypsin (α1ATp) concentrations in patients with SCS.
  
  
  METHODS
  We studied 35 patients (56.0 ± 15.0 years) with SCS and 33 healthy volunteers (53.3 ± 17.7 years). In all subjects the analysis of HCY and α1ATp concentration in serum was determined with an immunonephelometric method. P-values below 0.05 were considered statistically significant.
  
  
  RESULTS
  A comparison of HCY and α1ATp mean concentrations in patients with SCS and healthy representatives indicated statistically higher values of both analysed parameters in the sera of patients than in the healthy controls (p values were 0.018 and 0.008, respectively). In the patients with SCS a negative correlation between α1ATp and cortisol concentration in overnight dexamethasone test was found (p=0.017, R=-0.40). We did not reveal any statistically significant correlation between the concentrations of HCY and α1ATp, and coagulation parameters such as INR, APTT, fibrinogen concentration in patients with SCS.
  
  
  CONCLUSIONS
  On the basis of the obtained results, a slight increase in the concentration of homocysteine and α1ATp is observed in patients with SCS, which may influence vascular complications.
authors.affiliation: Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland. rensto@gumed.edu.pl
authors.forename: R
authors.initials: R
authors.lastname: Świątkowska-Stodulska
authors.forename: S
authors.initials: S
authors.lastname: Kaniuka-Jakubowska
authors.forename: P
authors.initials: P
authors.lastname: Wiśniewski
authors.forename: A
authors.initials: A
authors.lastname: Skibowska-Bielińska
authors.forename: A
authors.initials: A
authors.lastname: Babińska
authors.forename: E
authors.initials: E
authors.lastname: Sowińska-Przepiera
authors.forename: K
authors.initials: K
authors.lastname: Sworczak
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003480:Cushing Syndrome / Q000097:blood* / Q000150:complications; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000097:blood / Q000209:etiology; D000515:alpha 1-Antitrypsin / Q000097:blood*
chemical_list: D000515:alpha 1-Antitrypsin; D006710:Homocysteine; D006854:Hydrocortisone